Indivior plc (INDV) ORD USD0.5
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
London close: Stocks slip as US non-farm payrolls undershoot
6 September 2024 15:45
(Sharecast News) - London stocks ended lower on Friday, as disappointing US jobs data weighed on investor sentiment.
-
Indivior CUD study fails to meet primary and secondary endpoints
4 September 2024 08:53
(Sharecast News) - Drugmaker Indivior said on Wednesday that the primary and secondary endpoints of Aelis Farma's clinical Phase 2B study of AEF0117 use in participants with cannabis use disorder had...
-
London close: Stocks mixed on tsunami of updates, US GDP data
25 July 2024 15:27
(Sharecast News) - London stocks closed with mixed results on Thursday as investors processed faster-than-anticipated economic growth in the United States, following a heavy flow of corporate announcements...
-
Indivior shares rebound on $100m buyback plan
25 July 2024 08:47
(Sharecast News) - Indivior's share price surged on Thursday after the pharma group announced plans for $100m share buyback following a strong first-half performance, with second-quarter revenues in...
-
London close: Stocks mixed as UK inflation holds steady
17 July 2024 12:28
(Sharecast News) - London stocks ended mixed on Wednesday as the latest inflation data came in slightly higher than anticipated, casting doubt on a potential interest rate cut in August.
-
London close: Stocks slip as investors digest Powell's comments
9 July 2024 15:24
(Sharecast News) - London stocks ended in negative territory on Tuesday, driven by concerns over a decline in retail sales and the impact of comments from US Federal Reserve chair Jerome Powell.
-
Indivior shares plummet on profit warning, product discontinuation
9 July 2024 07:39
(Sharecast News) - Pharma group Indivior saw shares plummet on Tuesday after it issued a profit warning for 2024 on the back of "adverse market dynamics" affecting its Sublocade treatment, and...
-
Indivior reports first-quarter growth, confirms plans to shift main listing
25 April 2024 08:56
(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net revenue rising 12% year-on-year to $284m, as it confirmed...
-
Indivior receives settlement approval for antitrust litigation
29 February 2024 09:47
(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.
-
London close: Stocks rise amid raft of solid earnings
22 February 2024 16:26
(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.
-
Indivior planning to move primary listing to US, shares surge
22 February 2024 08:26
(Sharecast News) - Indivior surged on Thursday after the opioid addiction treatment maker said it was planning to move its primary listing to the US.
-
London close: Stocks rise as UK inflation slows further
20 December 2023 15:05
(Sharecast News) - London's stock markets saw a notable upswing on Wednesday, driven by encouraging data revealing a greater-than-anticipated slowdown in UK inflation for November.
Company announcements Announcements
-
Indivior Provides Update on AEF0117
4 September 2024 07:00
Indivior
-
Transaction in Own Shares
3 September 2024 07:00
Indivior
-
Total Voting Rights
2 September 2024 09:00
Indivior
-
Transaction in Own Shares
27 August 2024 07:00
Indivior
-
Transaction in Own Shares
20 August 2024 07:00
Indivior
-
Indivior to Participate in Upcoming Events
20 August 2024 07:00
Indivior
-
Holding(s) in Company
14 August 2024 07:36
Indivior
-
Transaction in Own Shares
13 August 2024 07:00
Indivior
-
Completion of Share Repurchase Program
6 August 2024 07:00
Indivior
-
Transaction in Own Shares
6 August 2024 07:00
Indivior
-
Total Voting Rights
1 August 2024 08:24
Indivior
-
Block Listings of Shares
30 July 2024 14:31
Indivior
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.